Baker Mark Robert

Avg. Two Year Performance

185% Avg. Purchase Return
69% Compound
(56%) Avg. Sale Return
(25%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return23%41%97%84%185%
Purchase Success Rate6 of 145 of 147 of 148 of 145 of 14
Average Sale Return17%10%22%(21%)(56%)
Sale Success Rate2 of 32 of 33 of 30 of 30 of 3
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 161.14K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--